Alkermes PLC Registered Shares DL -,01

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

81.60%

Market Cap

-

P/E Ratio

19.54

Dividend Yield

0.00 %

Earnings per Share

1.27 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE45.3 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 05:03:03 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW45.6144.93
PREV. DAY'S PRICE45.4 (07/20)
CHANGE DAY BEFORE
-0.10
-0.22 %
52 WEEK HIGH / LOW48.55 (07/07)22.2 (07/25)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
1.942.011.27-0.370.25
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
13.2313.2619.54-181.79
PRICE - BOOK RATIO
3.853.182.55--
PRICE - SALES RATIO
2.833.123.20--
PRICE - CASH FLOW RATIO
11.7311.089.07--
Further Key Figures

Master Data

WKN
A1JKVH
ISIN
IE00B56GVS15
SYMBOL
8AK
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Alkermes
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
0.11 %
17.19 %
57.64 %
68.15 %
81.60 %
62.46 %
131.85 %
92.37 %
HIGH46.5348.5548.5548.5548.5548.5548.5548.55
LOW43.9938.8028.0223.2022.2021.0018.3023.20

Dividende

pro Aktie
Alkermes does not deliver dividend information

Company profile

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.